Hui-Hui Hu
Overview
Explore the profile of Hui-Hui Hu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dong X, Hu H, Ying Z, Chen D, Xie J, Li D, et al.
Acta Ophthalmol
. 2024 Nov;
PMID: 39588880
The purpose of this study was to: (a) investigate the comorbidities of major sight-threatening eye disorders with mental disorders, (b) investigate the associations and prevalence of reported comorbidities and (c)...
2.
Pan Q, Xiong Y, Sha T, Feng Z, Zhou R, Yao J, et al.
Adv Mater
. 2024 Nov;
37(1):e2410585.
PMID: 39498715
Multiferroics are appealing because of application potentials in data storage devices, sensors, transducers, and energy harvesters. Molecular multiferroics emerge as a promising alternative to inorganic multiferroics due to flexibility, light...
3.
Dong X, Huang Y, Miao Y, Hu H, Pan C, Zhang T, et al.
JMIR Public Health Surveill
. 2024 Sep;
10:e57437.
PMID: 39267352
Background: Personality has an impact on the health-related quality of life (HRQoL) of older adults. However, the relationship and mechanisms of the 2 variables are controversial, and few studies have...
4.
Hu H, Xu X, Li X, Zeng Y, Li Y, Song X, et al.
Clin Transl Radiat Oncol
. 2024 Aug;
48:100818.
PMID: 39091465
Background: Chemotherapy plus immunotherapy has become the standard first-line treatment of advanced or metastatic esophageal squamous cell carcinoma (ESCC), but median duration of response is only 7.0-8.3 months and progression-free...
5.
Xiong Y, Duan S, Hu H, Yao J, Pan Q, Sha T, et al.
Nat Commun
. 2024 May;
15(1):4470.
PMID: 38796520
Molecular ferroelectrics are attracting great interest due to their light weight, mechanical flexibility, low cost, ease of processing and environmental friendliness. These advantages make molecular ferroelectrics viable alternatives or supplements...
6.
Hu H, Wang S, Shang H, Lv H, Chen B, Gao S, et al.
Front Pharmacol
. 2024 Feb;
15:1274209.
PMID: 38410129
Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase that exhibits high expression in various tumors and is associated with a poor prognosis. FAK activation promotes tumor growth, invasion, metastasis,...
7.
Hu H, Wang S, Zhao H, Chen Z, Shi X, Chen X
Int J Oncol
. 2024 Feb;
64(4).
PMID: 38391024
Human epidermal growth factor receptor 2 (HER2) gastric cancer (GC) is a distinct subtype of GC, accounting for 10‑20% of all cases of GC. Although the development of the anti‑HER2...
8.
Wu Y, Zhang C, Xiong J, Cai D, Wang C, Liu Y, et al.
Cell Res
. 2023 Sep;
33(11):835-850.
PMID: 37726403
Glycolytic intermediary metabolites such as fructose-1,6-bisphosphate can serve as signals, controlling metabolic states beyond energy metabolism. However, whether glycolytic metabolites also play a role in controlling cell fate remains unexplored....
9.
Kai J, Li D, Hu H, Zhang X, Pan C
Invest Ophthalmol Vis Sci
. 2023 Jun;
64(7):23.
PMID: 37314755
Purpose: To assess the impacts of area-level socioeconomic and environmental measures on reduced visual acuity (VA). Methods: This ecological study used the nationally representative cross-sectional data from the Chinese National...
10.
Zhang Y, Hu H, Zhou S, Xia W, Zhang Y, Zhang J, et al.
Biomark Res
. 2023 Jan;
11(1):10.
PMID: 36694213
Background: Cumulative preclinical and clinical evidences showed radiotherapy might augment systemic antitumoral responses to immunotherapy for metastatic non-small cell lung cancer, but the optimal timing of combination is still unclear....